United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Sep 24, 2026 · Filed Sep 25, 2026

On Sep 24, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$473.55 for US$4.5M under a trading plan, leaving 324,443 shares. Filed Sep 25, 2026 (Form 4).

Sold
9,500 shares
Price
US$473.55 average (US$469.74 to US$480.33)
Value
US$4.5M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 24, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Sep 24, 2026Common StockSale640US$469.74333,303Indirect
Sep 24, 2026Common StockSale2,603US$470.63330,700Indirect
Sep 24, 2026Common StockSale2,160US$471.77328,540Indirect
Sep 24, 2026Common StockSale580US$472.73327,960Indirect
Sep 24, 2026Common StockSale437US$474.01327,523Indirect
Sep 24, 2026Common StockSale320US$475.35327,203Indirect
Sep 24, 2026Common StockSale280US$476.51326,923Indirect
Sep 24, 2026Common StockSale360US$477.58326,563Indirect
Sep 24, 2026Common StockSale1,480US$478.61325,083Indirect
Sep 24, 2026Common StockSale600US$479.52324,483Indirect
Sep 24, 2026Common StockSale40US$480.33324,443Indirect

Source

View original at SEC

Related